Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

ReShape Lifesciences Inc (RSLS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow ReShape Lifesciences's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.167 -0.011    -6.18%
10:43:24 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 156,675
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.167 - 0.182
ReShape Lifesciences 0.167 -0.011 -6.18%

ReShape Lifesciences Inc Company Profile

 
Get an in-depth profile of ReShape Lifesciences Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

29

Equity Type

ORD

ReShape Lifesciences Inc. provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual’s comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus. It is also involved in developing ReShape Obalon Balloon System, consists of a swallowable capsule that tracks and displays the location of the balloon during placement; and ReShape Diabetes Bloc-Stim Neuromodulation (DBSN) device, a technology that is in development for the treatment of type 2 diabetes mellitus. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in Irvine, California.

Contact Information

Address 18 Technology Drive Suite 110
Irvine, 92618
United States
Phone 949-429-6680
Fax -

Top Executives

Name Age Since Title
Scott A. Shikora 65 2010 Member of Scientific Advisory Board
Jaime Ponce - 2018 Member of Scientific Advisory Board
Ardaeviraf Minocher Minocherhomjee 69 2018 Independent Director
Dan W. Gladney 71 2015 Executive Chair
Gary D. Blackford 67 2016 Independent Lead Director
Lori C. McDougal 63 2015 Independent Director
John Morton - 2018 Member of Scientific Advisory Board
Paul F. Hickey 59 2016 CEO, President & Director
Natan Zundel - 2018 Member of Scientific Advisory Board
Philip R. Schauer - 2018 Member of Scientific Advisory Board
Adam Smith - 2023 Member of Scientific Advisory Board
Christine Ren-Fielding - 2023 Member of Scientific Advisory Board
Shaw Somers - 2023 Member of Scientific Advisory Board
Carl Pesta - 2023 Member of Scientific Advisory Board
John Dixon - 2023 Member of Scientific Advisory Board
Erik Wilson - 2023 Member of Scientific Advisory Board
Matt Brengman - 2023 Member of Scientific Advisory Board
Francesco Furbetta - 2023 Member of Scientific Advisory Board
Caroline M. Apovian - 2023 Member of Scientific Advisory Board
Michael Baptista - 2023 Member of Scientific Advisory Board
Michael Orris - 2023 Member of Scientific Advisory Board
Darrin Hansen - 2023 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RSLS Comments

Write your thoughts about ReShape Lifesciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
jose nunez
jose nunez Jul 09, 2023 3:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is this still a pump and dump with infinite reverse splits?
Nhat Doan
Nhat Doan Dec 23, 2022 7:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
TEST Can Not Short 👉 No Buy => Delete
Szoka Krisztian
Szoka Krisztian Aug 06, 2021 12:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Wow! Best earning ever! Go up!
Aket Orem
Aket Orem Jul 12, 2021 2:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Best robot trader of the century
Aket Orem
Aket Orem Jun 29, 2021 4:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I’m in 🚀
Episcopolian OptionTrader
Episcopolian1 Jun 18, 2021 2:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
12:52 PM EDT, 06/17/2021 $ RSLS is a total buy with PT of $18.5 12:52 PM EDT, 06/17/2021 --Alliance Global Partners Adjusts ReShape Lifesciences PT to $18.50 From $12, Maintains Buy Rating
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email